IPO Schedule: Week of May 4

The week of May 4 is turning out to be a very busy one for the IPO market. Here is a schedule of when the underwriters expect their respective deals to debut. If you indicate for IPOs, I would encourage you to look at our subscription plans so that you can allocate your money to the best IPOs each week. Below is the schedule for when deals next week are scheduled to debut.

Wednesday, May 6

AdaptImmune Therapeutics (Nasdaq: ADAP)
Gelesis, Inc. (Nasdaq: GLSS)
Multivir (Nasdaq: MVIR)
HTG Molecular Diagnostics (Nasdaq: HTGM)
Colucid Pharmaceuticals (Nasdaq: CLCD)

Thursday, May 7

aTyr Pharma (Nasdaq: LIFE)
Collegium Pharmaceutical (Nasdaq: COLL)
Commercial Credit (NYSE: CCR)
Tallgrass Energy GP, LP (NYSE: TEGP)
Klox Technologies (Nasdaq: KLOX)

Friday, May 8

Bojangles (Nasdaq: BOJA)
Anterios (Nasdaq: ANTE)
International Market Centers (NYSE: IMC)